psychedelics investing Optimi Health Completes Psilocybin Export to Australia for Treatment Resistant Depression
psychedelics investing Optimi Health Reports First MDMA-Assisted Treatments of 2026 are Underway Across an Expanded Network of Australian Clinics
psychedelics investing Optimi Health Completes MDMA Export for PTSD Treatment Under Australia's Authorised Prescriber Scheme
psychedelics investing Optimi Health to Present at the Sidoti Micro-Cap Conference on January 21-22, 2026
psychedelics investing Optimi Health to Supply MDMA to MAPS Israel's Clinical Trial for Trauma-Related PTSD
psychedelics investing Optimi Announces Public Filing of Registration Statement for Proposed U.S. Initial Public Offering
psychedelics investing Optimi Health Announces Launch of Psilocybin Capsules in Australia for Treatment-Resistant Depression
